World Kidney Day 2017 was celebrated in more that 90 countries around the world. This major success was made possible by the support of our Global Corporate Contributors.
Partners
Supporters
Benefactors
The mission of Danone Research is to bring health through food to the greatest number of people.
With 150 manufacturing sites and over 75,000 employees, Danone is a health food leader. The waters division of the Danone Group encompasses several well known international brands including Evian, Volvic, Badoit and Bonafont, as well as leading national brands such as Aqua (Indonesia), Villavicencio, Villa del Sur (Argentina), Zywiec Zdroj (Poland), Hayat (Turkey), Fontvella, Lanjaron (Spain), Salus (Uruguay), Robust, Health (China) and Salvetat (France). Danone is committed to promoting healthy hydration. Our aim is to encourage scientific advances in hydration studies, and ensure the diffusion and application of this information through our the Hydration for Health Initiative.
www.danone.com
Amgen discovers, develops, manufactures and delivers innovative human therapeutics.
A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives.
www.amgen.com
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
www.astrazeneca.com/
Akebia Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor biology.
Akebia’s lead product candidate, vadadustat, is an oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients.
www.akebia.com
Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.
As a global, diversified healthcare company, Baxter International Inc. applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
www.baxter.com
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 99,600 people and had sales of EUR 34.9 billion. Capital expenditures amounted to EUR 2.2 billion, R&D expenses to EUR 4.4 billion.
For more information, go to www.bayer.com.
Fresenius Medical Care is the world’s largest provider of products and services for individuals with renal diseases of which more than 3 million patients worldwide regularly undergo dialysis treatment.
Through its network of more than 3,714 dialysis clinics, Fresenius Medical Care provides dialysis treatments for around 320,00 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with the core business, the company focuses on expanding the range of related medical services in the field of Care Coordination.
www.freseniusmedicalcare.com
We have great ambitions for 2018. Our 2018 theme, Kidneys & Women’s Health – Include, Value, Empower, is one of major importance and we have many challenges to face.
We have a large awareness campaign to run to promote preventive behaviors, encourage early screening of people with diabetes and hypertension, and stimulate positive thinking about organ donation and transplantation. We need the means to do so and you can help!
Click for information about Sponsor Packages
To become a World Kidney Day sponsor, please contact:
Wessel Nieuwenweg, WKD Business Development Director
Email: wessel@worldkidneyday.org
World Kidney Day (WKD) is a global awareness campaign aimed at raising awareness about the importance of our kidneys. WKD is a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations(IFKF) who, together, generate WKD campaign content, educational material and activities. The annual campaign is overseen by the WKD Steering Committee composed of nephrology and transplantation experts who live and work in Africa, Asia, Australia, Europe, South America and North America. Financial support is solicited with the sole purpose of carrying out the campaign’s core activities and achieving campaign objectives. Our contributors provide financial support to carry out our activities, help us disseminate our message and strengthen our efforts, which WKD is very grateful for. However, contributors do not take part in any of the decision making and do not influence any of the content or messages disseminated by WKD.